Short-Term Mortality Risk in Dementia Patients Initiating Opioids: A Retrospective Cohort Study Comparing New Users and Consistent Users

Yeon Mi Hwang,Jennifer Myunghae Hah,Tina Hernandez-Boussard

DOI: https://doi.org/10.1101/2024.11.25.24317747

2024-11-26

Abstract:The opioid epidemic continues to grow, and while the adverse effects of opioids are well–known, their impact on short-term mortality in patients with dementia or mild cognitive impairment (MCI) remains understudied, despite the high vulnerability of this population. To evaluate the short-term mortality risk associated with initiating opioids in patients diagnosed with dementia or MCI Retrospective observational cohort study Multisite healthcare system in Northern California Health records of 27,759 patients aged 50–100 with dementia or MCI, with encounters between January 1, 2015, and July 31, 2024. Exclusions included patients who died within 14 days of surgery, had fewer than three clinical encounters before and after diagnosis, or were first diagnosed with dementia/MCI at death. Initial opioid use following dementia or MCI onset. Patients were categorized as new users (no opioid use in the prior year) or consistent users (prior opioid exposure). Short–term mortality risk, defined as death within 14 days of first opioid exposure, with additional monitoring up to 60 days after opioid initiation. Hazard ratios were calculated using Cox proportional hazards regression, adjusting for demographics, comorbidities, and medication exposure. We used GPT.3.5–Turbo to identify possible causes of death from unstructured clinical documentation, supplemented by data from California public death records. Among 14,107 patients prescribed opioids following the onset of dementia/MCI onset, 9444 were new users and 4663 were consistent users. The cohort was predominantly female (56.0%), with a median age of 81 years (IQR:73–87). New users exhibited a 1.95–fold (95% CI, 1.55 – 2.46; P < 0.0001) increased risk of mortality within 14 days of initial opioid exposure compared to consistent users. Respiratory illnesses were more prevalent among new users who died within 14 days after opioid exposure (62% vs. 48%, P<0.1), particularly pneumonia (38% vs. 19%, P<0.01). Opioid initiation in patients with dementia or MCI is linked to significantly higher short–term mortality, particularly in those with respiratory conditions. These findings highlight the need for cautious prescribing and close monitoring, given the increased mortality risk.

Geriatric Medicine